Brief: Enanta Pharmaceuticals Q1 Revenue USD 16.959 Million
10/02/2025 21:01
Feb 10 (Reuters) - Enanta Pharmaceuticals Q1 operating expenses USD 40.502 million. * Q1 pretax profit USD -22.706 million * Q1 net income USD -22.29 million * Q1 operating income USD -23.543 million
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates